These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7759161)
21. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model. Pedley RB; Boden JA; Boden R; Dale R; Begent RH Br J Cancer; 1993 Jul; 68(1):69-73. PubMed ID: 8318423 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. Juweid M; Sharkey RM; Swayne LC; Griffiths GL; Dunn R; Goldenberg DM J Nucl Med; 1998 Jan; 39(1):34-42. PubMed ID: 9443735 [TBL] [Abstract][Full Text] [Related]
23. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy. Mayer R; Dillehay LE; Shao Y; Zhang YG; Song S; Bartholomew RM; Mackenson DG; Williams JR Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):147-57. PubMed ID: 7721611 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model. Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734 [TBL] [Abstract][Full Text] [Related]
25. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. Sharkey RM; Pykett MJ; Siegel JA; Alger EA; Primus FJ; Goldenberg DM Cancer Res; 1987 Nov; 47(21):5672-7. PubMed ID: 3664474 [TBL] [Abstract][Full Text] [Related]
26. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts. Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435 [TBL] [Abstract][Full Text] [Related]
27. High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial. Tempero M; Leichner P; Baranowska-Kortylewicz J; Harrison K; Augustine S; Schlom J; Anderson J; Wisecarver J; Colcher D Clin Cancer Res; 2000 Aug; 6(8):3095-102. PubMed ID: 10955789 [TBL] [Abstract][Full Text] [Related]
29. Suppression of tumor vascular activity by radioantibody therapy: implications for multiple cycle treatments. Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM Sel Cancer Ther; 1991; 7(1):9-16. PubMed ID: 1925118 [TBL] [Abstract][Full Text] [Related]
30. Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas. Blumenthal RD; Sharkey RM; Kashi R; Natale AM; Goldenberg DM Int J Cancer; 1992 Jul; 51(6):935-41. PubMed ID: 1322378 [TBL] [Abstract][Full Text] [Related]
31. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228 [TBL] [Abstract][Full Text] [Related]
32. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070 [TBL] [Abstract][Full Text] [Related]
33. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230 [TBL] [Abstract][Full Text] [Related]
34. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts. Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333 [TBL] [Abstract][Full Text] [Related]
35. The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors. Boerman OC; Sharkey RM; Blumenthal RD; Aninipot RL; Goldenberg DM Int J Cancer; 1992 May; 51(3):470-5. PubMed ID: 1592537 [TBL] [Abstract][Full Text] [Related]
36. Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Bhatia J; Morris R; Begent RH Int J Radiat Biol; 2002 May; 78(5):407-15. PubMed ID: 12020430 [TBL] [Abstract][Full Text] [Related]
37. Experimental radioimmunotherapy with 186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: comparison with 131I-counterpart. Kinuya S; Yokoyama K; Kobayashi K; Motoishi S; Onoma K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N Ann Nucl Med; 2001 Jun; 15(3):199-202. PubMed ID: 11545188 [TBL] [Abstract][Full Text] [Related]
38. Prediction of tumor response to experimental radioimmunotherapy with 90Y in nude mice. Dillehay LE; Mayer R; Zhang YG; Shao Y; Song SY; Mackensen DG; Williams JR Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):417-27. PubMed ID: 7673029 [TBL] [Abstract][Full Text] [Related]
39. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357 [TBL] [Abstract][Full Text] [Related]
40. Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia. Blumenthal RD; Taylor A; Osorio L; Ochakovskaya R; Raleigh JA; Papadopoulou M; Bloomer WD; Goldenberg DM Int J Cancer; 2001 Nov; 94(4):564-71. PubMed ID: 11745445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]